A Prospective, Randomized and Double Blind Once-Monthly Oral Ibandronate and Risedronate in Post-Menopausal Osteoporosis Leprosy Patients. Int J of Biomed & Adv Res 2017, 8 (11), 407-415. https://doi.org/10.7439/ijbar.v8i11.4474.